Metabolism of steroid hormones (Homo sapiens)
From WikiPathways
Description
Steroid hormones are synthesized primarily in the adrenal gland and gonads. They regulate energy metabolism and stress responses (glucocorticoids), salt balance (mineralocorticoids), and sexual development and function (androgens and estrogens). All steroids are synthesized from cholesterol. Steroid hormone synthesis is largely regulated at the initial steps of cholesterol mobilization and transport into the mitochondrial matrix for conversion to pregnenolone. In the body, the fate of pregnenolone is tissue-specific: in the zona fasciculata of the adrenal cortex it is converted to cortisol, in the zona glomerulosa to aldosterone, and in the gonads to testosterone and then to estrone and estradiol. These pathways are outlined in the figure below, which also details the sites on the cholesterol molecule that undergo modification in the course of these reactions.
Vitamin D3 (cholecalciferol) is a steroid hormone that plays a role in regulating calcium and bone metabolism. The processes by which it is synthesized, modified, and transported in the body are annotated here. Source:Reactome.</div>
Quality Tags
Ontology Terms
Bibliography
View all... |
- Toda K, Terashima M, Kawamoto T, Sumimoto H, Yokoyama Y, Kuribayashi I, Mitsuuchi Y, Maeda T, Yamamoto Y, Sagara Y.; ''Structural and functional characterization of human aromatase P-450 gene.''; PubMed Europe PMC Scholia
- Stewart PM, Wallace AM, Valentino R, Burt D, Shackleton CH, Edwards CR.; ''Mineralocorticoid activity of liquorice: 11-beta-hydroxysteroid dehydrogenase deficiency comes of age.''; PubMed Europe PMC Scholia
- Galiègue S, Jbilo O, Combes T, Bribes E, Carayon P, Le Fur G, Casellas P.; ''Cloning and characterization of PRAX-1. A new protein that specifically interacts with the peripheral benzodiazepine receptor.''; PubMed Europe PMC Scholia
- Simpson ER, Mahendroo MS, Means GD, Kilgore MW, Hinshelwood MM, Graham-Lorence S, Amarneh B, Ito Y, Fisher CR, Michael MD.; ''Aromatase cytochrome P450, the enzyme responsible for estrogen biosynthesis.''; PubMed Europe PMC Scholia
- Du J, Wang Y, Hunter R, Wei Y, Blumenthal R, Falke C, Khairova R, Zhou R, Yuan P, Machado-Vieira R, McEwen BS, Manji HK.; ''Dynamic regulation of mitochondrial function by glucocorticoids.''; PubMed Europe PMC Scholia
- Gargano EM, Allegretta G, Perspicace E, Carotti A, Van Koppen C, Frotscher M, Marchais-Oberwinkler S, Hartmann RW.; ''17β-Hydroxysteroid Dehydrogenase Type 2 Inhibition: Discovery of Selective and Metabolically Stable Compounds Inhibiting Both the Human Enzyme and Its Murine Ortholog.''; PubMed Europe PMC Scholia
- Kawainoto T, Mitsuuchi Y, Ohnishi T, Ichikawa Y, Yokoyama Y, Sumimoto H, Toda K, Miyahara K, Kuribayashi I, Nakao K.; ''Cloning and expression of a cDNA for human cytochrome P-450aldo as related to primary aldosteronism.''; PubMed Europe PMC Scholia
- White PC, New MI, Dupont B.; ''Structure of human steroid 21-hydroxylase genes.''; PubMed Europe PMC Scholia
- Létourneau D, Lefebvre A, Lavigne P, LeHoux JG.; ''The binding site specificity of STARD4 subfamily: Breaking the cholesterol paradigm.''; PubMed Europe PMC Scholia
- De Souza EB, Anholt RR, Murphy KM, Snyder SH, Kuhar MJ.; ''Peripheral-type benzodiazepine receptors in endocrine organs: autoradiographic localization in rat pituitary, adrenal, and testis.''; PubMed Europe PMC Scholia
- Geissler WM, Davis DL, Wu L, Bradshaw KD, Patel S, Mendonca BB, Elliston KO, Wilson JD, Russell DW, Andersson S.; ''Male pseudohermaphroditism caused by mutations of testicular 17 beta-hydroxysteroid dehydrogenase 3.''; PubMed Europe PMC Scholia
- Lin D, Chang YJ, Strauss JF, Miller WL.; ''The human peripheral benzodiazepine receptor gene: cloning and characterization of alternative splicing in normal tissues and in a patient with congenital lipoid adrenal hyperplasia.''; PubMed Europe PMC Scholia
- Tannin GM, Agarwal AK, Monder C, New MI, White PC.; ''The human gene for 11 beta-hydroxysteroid dehydrogenase. Structure, tissue distribution, and chromosomal localization.''; PubMed Europe PMC Scholia
- Anholt RR, Pedersen PL, De Souza EB, Snyder SH.; ''The peripheral-type benzodiazepine receptor. Localization to the mitochondrial outer membrane.''; PubMed Europe PMC Scholia
- Thomas JL, Duax WL, Addlagatta A, Brandt S, Fuller RR, Norris W.; ''Structure/function relationships responsible for coenzyme specificity and the isomerase activity of human type 1 3 beta-hydroxysteroid dehydrogenase/isomerase.''; PubMed Europe PMC Scholia
- Luu-The V, Labrie C, Zhao HF, Couët J, Lachance Y, Simard J, Côté J, Leblanc G, Lagacé L, Bérubé D.; ''Purification, cloning, complementary DNA structure, and predicted amino acid sequence of human estradiol 17 beta-dehydrogenase.''; PubMed Europe PMC Scholia
- Payne AH, Hales DB.; ''Overview of steroidogenic enzymes in the pathway from cholesterol to active steroid hormones.''; PubMed Europe PMC Scholia
- Sivik T, Gunnarsson C, Fornander T, Nordenskjöld B, Skoog L, Stål O, Jansson A.; ''17β-Hydroxysteroid dehydrogenase type 14 is a predictive marker for tamoxifen response in oestrogen receptor positive breast cancer.''; PubMed Europe PMC Scholia
- Andersson S, Berman DM, Jenkins EP, Russell DW.; ''Deletion of steroid 5 alpha-reductase 2 gene in male pseudohermaphroditism.''; PubMed Europe PMC Scholia
- Mornet E, Dupont J, Vitek A, White PC.; ''Characterization of two genes encoding human steroid 11 beta-hydroxylase (P-450(11) beta).''; PubMed Europe PMC Scholia
- Rodrigues NR, Dunham I, Yu CY, Carroll MC, Porter RR, Campbell RD.; ''Molecular characterization of the HLA-linked steroid 21-hydroxylase B gene from an individual with congenital adrenal hyperplasia.''; PubMed Europe PMC Scholia
- Dong Y, Qiu QQ, Debear J, Lathrop WF, Bertolini DR, Tamburini PP.; ''17Beta-hydroxysteroid dehydrogenases in human bone cells.''; PubMed Europe PMC Scholia
- Kawamoto T, Mitsuuchi Y, Toda K, Yokoyama Y, Miyahara K, Miura S, Ohnishi T, Ichikawa Y, Nakao K, Imura H.; ''Role of steroid 11 beta-hydroxylase and steroid 18-hydroxylase in the biosynthesis of glucocorticoids and mineralocorticoids in humans.''; PubMed Europe PMC Scholia
- Andersson S, Russell DW.; ''Structural and biochemical properties of cloned and expressed human and rat steroid 5 alpha-reductases.''; PubMed Europe PMC Scholia
- Lukacik P, Keller B, Bunkoczi G, Kavanagh KL, Lee WH, Adamski J, Oppermann U.; ''Structural and biochemical characterization of human orphan DHRS10 reveals a novel cytosolic enzyme with steroid dehydrogenase activity.''; PubMed Europe PMC Scholia
- Rhéaume E, Lachance Y, Zhao HF, Breton N, Dumont M, de Launoit Y, Trudel C, Luu-The V, Simard J, Labrie F.; ''Structure and expression of a new complementary DNA encoding the almost exclusive 3 beta-hydroxysteroid dehydrogenase/delta 5-delta 4-isomerase in human adrenals and gonads.''; PubMed Europe PMC Scholia
- Chung BC, Matteson KJ, Voutilainen R, Mohandas TK, Miller WL.; ''Human cholesterol side-chain cleavage enzyme, P450scc: cDNA cloning, assignment of the gene to chromosome 15, and expression in the placenta.''; PubMed Europe PMC Scholia
- Dunn JF, Nisula BC, Rodbard D.; ''Transport of steroid hormones: binding of 21 endogenous steroids to both testosterone-binding globulin and corticosteroid-binding globulin in human plasma.''; PubMed Europe PMC Scholia
- Weber S, Salabei JK, Möller G, Kremmer E, Bhatnagar A, Adamski J, Barski OA.; ''Aldo-keto Reductase 1B15 (AKR1B15): a mitochondrial human aldo-keto reductase with activity toward steroids and 3-keto-acyl-CoA conjugates.''; PubMed Europe PMC Scholia
- Jaquinod M, Potier N, Klarskov K, Reymann JM, Sorokine O, Kieffer S, Barth P, Andriantomanga V, Biellmann JF, Van Dorsselaer A.; ''Sequence of pig lens aldose reductase and electrospray mass spectrometry of non-covalent and covalent complexes.''; PubMed Europe PMC Scholia
- Woods ST, Sadleir J, Downs T, Triantopoulos T, Headlam MJ, Tuckey RC.; ''Expression of catalytically active human cytochrome p450scc in Escherichia coli and mutagenesis of isoleucine-462.''; PubMed Europe PMC Scholia
- Hammond GL, Smith CL, Goping IS, Underhill DA, Harley MJ, Reventos J, Musto NA, Gunsalus GL, Bardin CW.; ''Primary structure of human corticosteroid binding globulin, deduced from hepatic and pulmonary cDNAs, exhibits homology with serine protease inhibitors.''; PubMed Europe PMC Scholia
- Lachance Y, Luu-The V, Labrie C, Simard J, Dumont M, de Launoit Y, Guérin S, Leblanc G, Labrie F.; ''Characterization of human 3 beta-hydroxysteroid dehydrogenase/delta 5-delta 4-isomerase gene and its expression in mammalian cells.''; PubMed Europe PMC Scholia
- Chai Z, Brereton P, Suzuki T, Sasano H, Obeyesekere V, Escher G, Saffery R, Fuller P, Enriquez C, Krozowski Z.; ''17 beta-hydroxysteroid dehydrogenase type XI localizes to human steroidogenic cells.''; PubMed Europe PMC Scholia
- Auchus RJ, Miller WL.; ''Molecular modeling of human P450c17 (17alpha-hydroxylase/17,20-lyase): insights into reaction mechanisms and effects of mutations.''; PubMed Europe PMC Scholia
- Luu-The V, Zhang Y, Poirier D, Labrie F.; ''Characteristics of human types 1, 2 and 3 17 beta-hydroxysteroid dehydrogenase activities: oxidation/reduction and inhibition.''; PubMed Europe PMC Scholia
- Anwar R, Gilbey SG, New JP, Markham AF.; ''Male pseudohermaphroditism resulting from a novel mutation in the human steroid 5 alpha-reductase type 2 gene (SRD5A2).''; PubMed Europe PMC Scholia
- Wu L, Einstein M, Geissler WM, Chan HK, Elliston KO, Andersson S.; ''Expression cloning and characterization of human 17 beta-hydroxysteroid dehydrogenase type 2, a microsomal enzyme possessing 20 alpha-hydroxysteroid dehydrogenase activity.''; PubMed Europe PMC Scholia
- Miller WL.; ''StAR search--what we know about how the steroidogenic acute regulatory protein mediates mitochondrial cholesterol import.''; PubMed Europe PMC Scholia
- Thomas JL, Myers RP, Strickler RC.; ''Human placental 3 beta-hydroxy-5-ene-steroid dehydrogenase and steroid 5----4-ene-isomerase: purification from mitochondria and kinetic profiles, biophysical characterization of the purified mitochondrial and microsomal enzymes.''; PubMed Europe PMC Scholia
- Strushkevich N, MacKenzie F, Cherkesova T, Grabovec I, Usanov S, Park HW.; ''Structural basis for pregnenolone biosynthesis by the mitochondrial monooxygenase system.''; PubMed Europe PMC Scholia
- Uemura M, Tamura K, Chung S, Honma S, Okuyama A, Nakamura Y, Nakagawa H.; ''Novel 5 alpha-steroid reductase (SRD5A3, type-3) is overexpressed in hormone-refractory prostate cancer.''; PubMed Europe PMC Scholia
- Ray P, Strott CA.; ''Cytosol stimulation of pregnenolone synthesis by isolated adrenal mitochondria.''; PubMed Europe PMC Scholia
- McKenna TJ, Fearon U, Clarke D, Cunningham SK.; ''A critical review of the origin and control of adrenal androgens.''; PubMed Europe PMC Scholia
- Matsuura K, Deyashiki Y, Bunai Y, Ohya I, Hara A.; ''Aldose reductase is a major reductase for isocaproaldehyde, a product of side-chain cleavage of cholesterol, in human and animal adrenal glands.''; PubMed Europe PMC Scholia
- Moeller G, Adamski J.; ''Integrated view on 17beta-hydroxysteroid dehydrogenases.''; PubMed Europe PMC Scholia
- Papadopoulos V, Aghazadeh Y, Fan J, Campioli E, Zirkin B, Midzak A.; ''Translocator protein-mediated pharmacology of cholesterol transport and steroidogenesis.''; PubMed Europe PMC Scholia
History
View all... |
External references
DataNodes
View all... |
Name | Type | Database reference | Comment |
---|---|---|---|
11-deoxycortisol | Metabolite | CHEBI:28324 (ChEBI) | |
11DCORST | Metabolite | CHEBI:16973 (ChEBI) | |
11DCORT | Metabolite | CHEBI:28324 (ChEBI) | |
17aHPREG | Metabolite | CHEBI:28750 (ChEBI) | |
17aHPROG | Metabolite | CHEBI:17252 (ChEBI) | |
18HCORST | Metabolite | CHEBI:16485 (ChEBI) | |
20a,22b-DHCHOL | Metabolite | CHEBI:1294 (ChEBI) | |
22beta-hydroxycholesterol | Metabolite | CHEBI:1301 (ChEBI) | |
7-dehydrocholesterol | Metabolite | CHEBI:17759 (ChEBI) | |
AKR1B1 | Protein | P15121 (Uniprot-TrEMBL) | |
ALDO | Metabolite | CHEBI:27584 (ChEBI) | |
ANDST | Metabolite | CHEBI:16422 (ChEBI) | |
CDL | Metabolite | CHEBI:17933 (ChEBI) | |
CDL | Metabolite | CHEBI:17933 (ChEBI) | |
CGA | Protein | P01215 (Uniprot-TrEMBL) | |
CH3CHO | Metabolite | CHEBI:15343 (ChEBI) | |
CHOL | Metabolite | CHEBI:16113 (ChEBI) | |
COR | Metabolite | CHEBI:16962 (ChEBI) | |
CORST | Metabolite | CHEBI:16827 (ChEBI) | |
CORT | Metabolite | CHEBI:17650 (ChEBI) | |
CTA | Metabolite | CHEBI:47828 (ChEBI) | |
CTL | Metabolite | CHEBI:17823 (ChEBI) | |
CUBN | Protein | O60494 (Uniprot-TrEMBL) | |
CUBN:GC:CDL | Complex | R-HSA-350115 (Reactome) | |
CUBN | Protein | O60494 (Uniprot-TrEMBL) | |
CYP11A1 | Protein | P05108 (Uniprot-TrEMBL) | |
CYP11B2 | Protein | P19099 (Uniprot-TrEMBL) | |
CYP17A1 | Protein | P05093 (Uniprot-TrEMBL) | |
CYP19A1 | Protein | P11511 (Uniprot-TrEMBL) | |
CYP21A2 | Protein | P08686 (Uniprot-TrEMBL) | |
CYP24A1 | Protein | Q07973 (Uniprot-TrEMBL) | |
CYP27B1(?-508) | Protein | O15528 (Uniprot-TrEMBL) | The start coordinate is not yet known |
CYP2R1 | Protein | Q6VVX0 (Uniprot-TrEMBL) | |
Cubilin:DBP:Calcidiol | Complex | R-HSA-350085 (Reactome) | |
Cubilin:DBP:Calcidiol | Complex | R-HSA-350092 (Reactome) | |
Cytochrome P450 (CYP11B1 based) | Protein | R-HSA-3219421 (Reactome) | This CandidateSet contains sequences identified by William Pearson's analysis of Reactome catalyst entities. Catalyst entity sequences were used to identify analagous sequences that shared overall homology and active site homology. Sequences in this Candidate set were identified in an April 24, 2012 analysis. |
DBP:vitamin D3 | Complex | R-HSA-352339 (Reactome) | |
DHEA | Metabolite | CHEBI:28689 (ChEBI) | |
DHTEST | Metabolite | CHEBI:16330 (ChEBI) | |
E1 | Metabolite | CHEBI:17263 (ChEBI) | |
EST17b | Metabolite | CHEBI:16469 (ChEBI) | |
GC | Protein | P02774 (Uniprot-TrEMBL) | |
GC:CDL | Complex | R-HSA-209892 (Reactome) | |
GC | Protein | P02774 (Uniprot-TrEMBL) | |
H+ | Metabolite | CHEBI:15378 (ChEBI) | |
H2O | Metabolite | CHEBI:15377 (ChEBI) | |
HCOOH | Metabolite | CHEBI:30751 (ChEBI) | |
HSD11B1 | Protein | P28845 (Uniprot-TrEMBL) | |
HSD11B1 dimer | Complex | R-HSA-193980 (Reactome) | |
HSD17B1 | Protein | P14061 (Uniprot-TrEMBL) | |
HSD17B1 dimer | Complex | R-HSA-804966 (Reactome) | |
HSD17B3-like Proteins | Protein | R-HSA-3902489 (Reactome) | This CandidateSet contains sequences identified by William Pearson's analysis of Reactome catalyst entities. Catalyst entity sequences were used to identify analagous sequences that shared overall homology and active site homology. Sequences in this Candidate set were identified in an April 24, 2012 analysis. |
HSD2B1 or HSD3B2 dimer | Complex | R-HSA-196357 (Reactome) | |
HSD3B1 | Protein | P14060 (Uniprot-TrEMBL) | |
HSD3B2 | Protein | P26439 (Uniprot-TrEMBL) | |
ISCAL | Metabolite | CHEBI:17998 (ChEBI) | |
LGMN | Protein | Q99538 (Uniprot-TrEMBL) | |
LHB | Protein | P01229 (Uniprot-TrEMBL) | |
LRP2 | Protein | P98164 (Uniprot-TrEMBL) | |
Lutropin | Complex | R-HSA-378969 (Reactome) | |
MePeOH | Metabolite | CHEBI:63910 (ChEBI) | |
NAD+ | Metabolite | CHEBI:15846 (ChEBI) | |
NADH | Metabolite | CHEBI:16908 (ChEBI) | |
NADP+ | Metabolite | CHEBI:18009 (ChEBI) | |
NADPH | Metabolite | CHEBI:16474 (ChEBI) | |
O2 | Metabolite | CHEBI:15379 (ChEBI) | |
P4 | Metabolite | CHEBI:17026 (ChEBI) | |
POMC(138-176) | Protein | P01189 (Uniprot-TrEMBL) | |
PREG | Metabolite | CHEBI:16581 (ChEBI) | |
SRD5A1-3 | Protein | R-HSA-469656 (Reactome) | |
STAR | Protein | P49675 (Uniprot-TrEMBL) | |
STAR | Protein | P49675 (Uniprot-TrEMBL) | |
StAR-related
cholesterol-binding proteins | Protein | R-HSA-196094 (Reactome) | |
TEST | Metabolite | CHEBI:17347 (ChEBI) | |
VD3 | Metabolite | CHEBI:28940 (ChEBI) | |
VD3 | Metabolite | CHEBI:28940 (ChEBI) | |
cholesterol | Metabolite | CHEBI:16113 (ChEBI) | |
cholesterol:STAR | Complex | R-HSA-196090 (Reactome) | |
cholesterol:StAR-related protein | Complex | R-HSA-196124 (Reactome) | |
cholesterol | Metabolite | CHEBI:16113 (ChEBI) | |
pregn-5-ene-3,20-dione-17-ol | Metabolite | CHEBI:63843 (ChEBI) | |
pregn-5-ene-3,20-dione | Metabolite | CHEBI:63837 (ChEBI) |
Annotated Interactions
View all... |
Source | Target | Type | Database reference | Comment |
---|---|---|---|---|
11-deoxycortisol | Arrow | R-HSA-193981 (Reactome) | ||
11-deoxycortisol | R-HSA-194025 (Reactome) | |||
11DCORST | Arrow | R-HSA-193964 (Reactome) | ||
11DCORST | Arrow | R-HSA-193996 (Reactome) | ||
11DCORST | R-HSA-193996 (Reactome) | |||
11DCORST | R-HSA-194017 (Reactome) | |||
11DCORT | Arrow | R-HSA-194025 (Reactome) | ||
11DCORT | R-HSA-193997 (Reactome) | |||
17aHPREG | Arrow | R-HSA-193068 (Reactome) | ||
17aHPREG | R-HSA-193070 (Reactome) | |||
17aHPREG | R-HSA-196372 (Reactome) | |||
17aHPROG | Arrow | R-HSA-193072 (Reactome) | ||
17aHPROG | Arrow | R-HSA-193961 (Reactome) | ||
17aHPROG | R-HSA-193099 (Reactome) | |||
17aHPROG | R-HSA-193981 (Reactome) | |||
18HCORST | Arrow | R-HSA-193995 (Reactome) | ||
18HCORST | R-HSA-193965 (Reactome) | |||
20a,22b-DHCHOL | Arrow | R-HSA-193065 (Reactome) | ||
20a,22b-DHCHOL | R-HSA-193101 (Reactome) | |||
22beta-hydroxycholesterol | Arrow | R-HSA-193054 (Reactome) | ||
22beta-hydroxycholesterol | R-HSA-193065 (Reactome) | |||
7-dehydrocholesterol | R-HSA-209754 (Reactome) | |||
AKR1B1 | mim-catalysis | R-HSA-196060 (Reactome) | ||
ALDO | Arrow | R-HSA-193965 (Reactome) | ||
ANDST | Arrow | R-HSA-193073 (Reactome) | ||
ANDST | Arrow | R-HSA-193099 (Reactome) | ||
ANDST | R-HSA-193060 (Reactome) | |||
ANDST | R-HSA-193064 (Reactome) | |||
CDL | Arrow | R-HSA-209766 (Reactome) | ||
CDL | Arrow | R-HSA-209845 (Reactome) | ||
CDL | Arrow | R-HSA-350158 (Reactome) | ||
CDL | R-HSA-209766 (Reactome) | |||
CDL | R-HSA-209868 (Reactome) | |||
CDL | R-HSA-209944 (Reactome) | |||
CH3CHO | Arrow | R-HSA-193070 (Reactome) | ||
CH3CHO | Arrow | R-HSA-193099 (Reactome) | ||
COR | Arrow | R-HSA-194023 (Reactome) | ||
CORST | Arrow | R-HSA-194017 (Reactome) | ||
CORST | R-HSA-193995 (Reactome) | |||
CORT | Arrow | R-HSA-193997 (Reactome) | ||
CORT | Arrow | R-HSA-194036 (Reactome) | ||
CORT | R-HSA-194023 (Reactome) | |||
CORT | R-HSA-194036 (Reactome) | |||
CTA | Arrow | R-HSA-209765 (Reactome) | ||
CTL | Arrow | R-HSA-209868 (Reactome) | ||
CTL | R-HSA-209765 (Reactome) | |||
CUBN:GC:CDL | Arrow | R-HSA-350186 (Reactome) | ||
CUBN:GC:CDL | R-HSA-350168 (Reactome) | |||
CUBN | Arrow | R-HSA-350158 (Reactome) | ||
CUBN | R-HSA-350186 (Reactome) | |||
CYP11A1 | mim-catalysis | R-HSA-193054 (Reactome) | ||
CYP11A1 | mim-catalysis | R-HSA-193065 (Reactome) | ||
CYP11A1 | mim-catalysis | R-HSA-193101 (Reactome) | ||
CYP11B2 | mim-catalysis | R-HSA-193965 (Reactome) | ||
CYP11B2 | mim-catalysis | R-HSA-193995 (Reactome) | ||
CYP17A1 | mim-catalysis | R-HSA-193068 (Reactome) | ||
CYP17A1 | mim-catalysis | R-HSA-193070 (Reactome) | ||
CYP17A1 | mim-catalysis | R-HSA-193072 (Reactome) | ||
CYP17A1 | mim-catalysis | R-HSA-193099 (Reactome) | ||
CYP19A1 | mim-catalysis | R-HSA-193060 (Reactome) | ||
CYP19A1 | mim-catalysis | R-HSA-193143 (Reactome) | ||
CYP21A2 | mim-catalysis | R-HSA-193964 (Reactome) | ||
CYP21A2 | mim-catalysis | R-HSA-193981 (Reactome) | ||
CYP24A1 | mim-catalysis | R-HSA-209765 (Reactome) | ||
CYP27B1(?-508) | mim-catalysis | R-HSA-209868 (Reactome) | ||
CYP2R1 | mim-catalysis | R-HSA-209845 (Reactome) | ||
Cubilin:DBP:Calcidiol | Arrow | R-HSA-209760 (Reactome) | ||
Cubilin:DBP:Calcidiol | Arrow | R-HSA-350168 (Reactome) | ||
Cubilin:DBP:Calcidiol | R-HSA-209760 (Reactome) | |||
Cubilin:DBP:Calcidiol | R-HSA-350158 (Reactome) | |||
Cytochrome P450 (CYP11B1 based) | mim-catalysis | R-HSA-193997 (Reactome) | ||
Cytochrome P450 (CYP11B1 based) | mim-catalysis | R-HSA-194017 (Reactome) | ||
DBP:vitamin D3 | Arrow | R-HSA-209738 (Reactome) | ||
DBP:vitamin D3 | R-HSA-350147 (Reactome) | |||
DHEA | Arrow | R-HSA-193070 (Reactome) | ||
DHEA | R-HSA-193073 (Reactome) | |||
DHTEST | Arrow | R-HSA-469659 (Reactome) | ||
E1 | Arrow | R-HSA-193060 (Reactome) | ||
E1 | R-HSA-804969 (Reactome) | |||
EST17b | Arrow | R-HSA-193143 (Reactome) | ||
EST17b | Arrow | R-HSA-804969 (Reactome) | ||
GC:CDL | Arrow | R-HSA-209944 (Reactome) | ||
GC:CDL | R-HSA-350186 (Reactome) | |||
GC | Arrow | R-HSA-350147 (Reactome) | ||
GC | R-HSA-209738 (Reactome) | |||
GC | R-HSA-209944 (Reactome) | |||
H+ | Arrow | R-HSA-193073 (Reactome) | ||
H+ | Arrow | R-HSA-194023 (Reactome) | ||
H+ | Arrow | R-HSA-196350 (Reactome) | ||
H+ | Arrow | R-HSA-196372 (Reactome) | ||
H+ | R-HSA-193054 (Reactome) | |||
H+ | R-HSA-193060 (Reactome) | |||
H+ | R-HSA-193064 (Reactome) | |||
H+ | R-HSA-193065 (Reactome) | |||
H+ | R-HSA-193068 (Reactome) | |||
H+ | R-HSA-193070 (Reactome) | |||
H+ | R-HSA-193072 (Reactome) | |||
H+ | R-HSA-193099 (Reactome) | |||
H+ | R-HSA-193101 (Reactome) | |||
H+ | R-HSA-193143 (Reactome) | |||
H+ | R-HSA-193964 (Reactome) | |||
H+ | R-HSA-193965 (Reactome) | |||
H+ | R-HSA-193981 (Reactome) | |||
H+ | R-HSA-193995 (Reactome) | |||
H+ | R-HSA-193997 (Reactome) | |||
H+ | R-HSA-194017 (Reactome) | |||
H+ | R-HSA-196060 (Reactome) | |||
H+ | R-HSA-209765 (Reactome) | |||
H+ | R-HSA-209845 (Reactome) | |||
H+ | R-HSA-209868 (Reactome) | |||
H+ | R-HSA-469659 (Reactome) | |||
H+ | R-HSA-804969 (Reactome) | |||
H2O | Arrow | R-HSA-193054 (Reactome) | ||
H2O | Arrow | R-HSA-193060 (Reactome) | ||
H2O | Arrow | R-HSA-193065 (Reactome) | ||
H2O | Arrow | R-HSA-193068 (Reactome) | ||
H2O | Arrow | R-HSA-193070 (Reactome) | ||
H2O | Arrow | R-HSA-193072 (Reactome) | ||
H2O | Arrow | R-HSA-193099 (Reactome) | ||
H2O | Arrow | R-HSA-193101 (Reactome) | ||
H2O | Arrow | R-HSA-193143 (Reactome) | ||
H2O | Arrow | R-HSA-193964 (Reactome) | ||
H2O | Arrow | R-HSA-193965 (Reactome) | ||
H2O | Arrow | R-HSA-193981 (Reactome) | ||
H2O | Arrow | R-HSA-193995 (Reactome) | ||
H2O | Arrow | R-HSA-193997 (Reactome) | ||
H2O | Arrow | R-HSA-194017 (Reactome) | ||
H2O | Arrow | R-HSA-209765 (Reactome) | ||
H2O | Arrow | R-HSA-209845 (Reactome) | ||
H2O | Arrow | R-HSA-209868 (Reactome) | ||
HCOOH | Arrow | R-HSA-193060 (Reactome) | ||
HCOOH | Arrow | R-HSA-193143 (Reactome) | ||
HSD11B1 dimer | mim-catalysis | R-HSA-194023 (Reactome) | ||
HSD17B1 dimer | mim-catalysis | R-HSA-804969 (Reactome) | ||
HSD17B3-like Proteins | mim-catalysis | R-HSA-193064 (Reactome) | ||
HSD2B1 or HSD3B2 dimer | mim-catalysis | R-HSA-193052 (Reactome) | ||
HSD2B1 or HSD3B2 dimer | mim-catalysis | R-HSA-193073 (Reactome) | ||
HSD2B1 or HSD3B2 dimer | mim-catalysis | R-HSA-193961 (Reactome) | ||
HSD2B1 or HSD3B2 dimer | mim-catalysis | R-HSA-196350 (Reactome) | ||
HSD2B1 or HSD3B2 dimer | mim-catalysis | R-HSA-196372 (Reactome) | ||
ISCAL | Arrow | R-HSA-193101 (Reactome) | ||
ISCAL | Arrow | R-HSA-196125 (Reactome) | ||
ISCAL | R-HSA-196060 (Reactome) | |||
ISCAL | R-HSA-196125 (Reactome) | |||
LGMN | mim-catalysis | R-HSA-350158 (Reactome) | ||
LRP2 | mim-catalysis | R-HSA-350168 (Reactome) | ||
Lutropin | Arrow | R-HSA-193052 (Reactome) | ||
Lutropin | Arrow | R-HSA-193064 (Reactome) | ||
MePeOH | Arrow | R-HSA-196060 (Reactome) | ||
NAD+ | R-HSA-193073 (Reactome) | |||
NAD+ | R-HSA-196350 (Reactome) | |||
NAD+ | R-HSA-196372 (Reactome) | |||
NADH | Arrow | R-HSA-193073 (Reactome) | ||
NADH | Arrow | R-HSA-196350 (Reactome) | ||
NADH | Arrow | R-HSA-196372 (Reactome) | ||
NADP+ | Arrow | R-HSA-193054 (Reactome) | ||
NADP+ | Arrow | R-HSA-193060 (Reactome) | ||
NADP+ | Arrow | R-HSA-193064 (Reactome) | ||
NADP+ | Arrow | R-HSA-193065 (Reactome) | ||
NADP+ | Arrow | R-HSA-193068 (Reactome) | ||
NADP+ | Arrow | R-HSA-193070 (Reactome) | ||
NADP+ | Arrow | R-HSA-193072 (Reactome) | ||
NADP+ | Arrow | R-HSA-193099 (Reactome) | ||
NADP+ | Arrow | R-HSA-193101 (Reactome) | ||
NADP+ | Arrow | R-HSA-193143 (Reactome) | ||
NADP+ | Arrow | R-HSA-193964 (Reactome) | ||
NADP+ | Arrow | R-HSA-193965 (Reactome) | ||
NADP+ | Arrow | R-HSA-193981 (Reactome) | ||
NADP+ | Arrow | R-HSA-193995 (Reactome) | ||
NADP+ | Arrow | R-HSA-193997 (Reactome) | ||
NADP+ | Arrow | R-HSA-194017 (Reactome) | ||
NADP+ | Arrow | R-HSA-196060 (Reactome) | ||
NADP+ | Arrow | R-HSA-209765 (Reactome) | ||
NADP+ | Arrow | R-HSA-209845 (Reactome) | ||
NADP+ | Arrow | R-HSA-209868 (Reactome) | ||
NADP+ | Arrow | R-HSA-469659 (Reactome) | ||
NADP+ | Arrow | R-HSA-804969 (Reactome) | ||
NADP+ | R-HSA-194023 (Reactome) | |||
NADPH | Arrow | R-HSA-194023 (Reactome) | ||
NADPH | R-HSA-193054 (Reactome) | |||
NADPH | R-HSA-193060 (Reactome) | |||
NADPH | R-HSA-193064 (Reactome) | |||
NADPH | R-HSA-193065 (Reactome) | |||
NADPH | R-HSA-193068 (Reactome) | |||
NADPH | R-HSA-193070 (Reactome) | |||
NADPH | R-HSA-193072 (Reactome) | |||
NADPH | R-HSA-193099 (Reactome) | |||
NADPH | R-HSA-193101 (Reactome) | |||
NADPH | R-HSA-193143 (Reactome) | |||
NADPH | R-HSA-193964 (Reactome) | |||
NADPH | R-HSA-193965 (Reactome) | |||
NADPH | R-HSA-193981 (Reactome) | |||
NADPH | R-HSA-193995 (Reactome) | |||
NADPH | R-HSA-193997 (Reactome) | |||
NADPH | R-HSA-194017 (Reactome) | |||
NADPH | R-HSA-196060 (Reactome) | |||
NADPH | R-HSA-209765 (Reactome) | |||
NADPH | R-HSA-209845 (Reactome) | |||
NADPH | R-HSA-209868 (Reactome) | |||
NADPH | R-HSA-469659 (Reactome) | |||
NADPH | R-HSA-804969 (Reactome) | |||
O2 | R-HSA-193054 (Reactome) | |||
O2 | R-HSA-193060 (Reactome) | |||
O2 | R-HSA-193065 (Reactome) | |||
O2 | R-HSA-193068 (Reactome) | |||
O2 | R-HSA-193070 (Reactome) | |||
O2 | R-HSA-193072 (Reactome) | |||
O2 | R-HSA-193099 (Reactome) | |||
O2 | R-HSA-193101 (Reactome) | |||
O2 | R-HSA-193143 (Reactome) | |||
O2 | R-HSA-193964 (Reactome) | |||
O2 | R-HSA-193965 (Reactome) | |||
O2 | R-HSA-193981 (Reactome) | |||
O2 | R-HSA-193995 (Reactome) | |||
O2 | R-HSA-193997 (Reactome) | |||
O2 | R-HSA-194017 (Reactome) | |||
O2 | R-HSA-209765 (Reactome) | |||
O2 | R-HSA-209845 (Reactome) | |||
O2 | R-HSA-209868 (Reactome) | |||
P4 | Arrow | R-HSA-193052 (Reactome) | ||
P4 | R-HSA-193072 (Reactome) | |||
P4 | R-HSA-193964 (Reactome) | |||
POMC(138-176) | Arrow | R-HSA-193064 (Reactome) | ||
POMC(138-176) | Arrow | R-HSA-193070 (Reactome) | ||
POMC(138-176) | Arrow | R-HSA-193073 (Reactome) | ||
POMC(138-176) | Arrow | R-HSA-193997 (Reactome) | ||
POMC(138-176) | Arrow | R-HSA-469659 (Reactome) | ||
PREG | Arrow | R-HSA-193097 (Reactome) | ||
PREG | Arrow | R-HSA-193101 (Reactome) | ||
PREG | R-HSA-193068 (Reactome) | |||
PREG | R-HSA-193097 (Reactome) | |||
PREG | R-HSA-196350 (Reactome) | |||
R-HSA-193052 (Reactome) | Pregn-5-ene-3,20-dione isomerizes to progesterone. This reaction is catalyzed by the isomerase activity of 3 beta-HSD, associated with the endoplasmic reticulum membrane. The active form of the enzyme is a homodimer. The enzyme occurs in two isoforms that are similar in their biochemical properties but differ in their tissue expression: type I (HSD3B1) is found in placenta and skin, while type II (HSD3B2) is found in the adrenal glands and gonads. The hormone lutropin (LH) triggers ovulation and development of the corpus luteum, that in turn increases production of progesterone. | |||
R-HSA-193054 (Reactome) | Cholesterol and NADPH + H+ react to form 22beta-hydroxycholesterol, NADP+, and H2O, catalyzed by CYP11A (P450scc) associated with the inner mitochondrial membrane. | |||
R-HSA-193060 (Reactome) | The conversion of androstenedione (ANDST) to estrone (E1) is catalysed by aromatase (CYP19A1) associated with the endoplasmic reticulum membrane (Toda et al. 1990, Simpson et al. 1994). | |||
R-HSA-193064 (Reactome) | The 17HSD family of enzymes catalyze the final step in the synthesis of estradiol and testosterone. They convert inactive 17-ketosteroids to their active 17beta-hydroxy forms. Androstenedione, a ketosteroid, is reduced to testosterone, a highly potent androgen, by the enzyme 17beta-hydroxysteroid dehydrogenase isoform III (17HSD3). The other human isoforms of 17HSDs to take part in the final steps of active steroid biosynthesis are types 1 and VII, which reduce estrone to estradiol. Corticotropin (Adrenocorticotropic hormone, ACTH) acts through the ACTH receptor called melanocortin receptor type 2 (MC2R) to stimulate steroidogenesis, increasing the production of androgens (McKenna et al, 1997). In males, Lutropin (LH) stimulates testosterone production. | |||
R-HSA-193065 (Reactome) | 22beta-hydroxycholesterol, NADPH + H+, and O2 react to form 20alpha,22beta-hydroxycholesterol, NADP+ and H2O, catalyzed by CYP11A (P450scc) associated with the inner mitochondrial membrane. | |||
R-HSA-193068 (Reactome) | Pregnenolone (PREG) and NADPH + H+ react to form 17alpha-hydroxypregnenolone (17aHPREG), NADP+, and H2O. Steroid 17 alpha hydroxylase/17,20 lyase (CYP17A1), associated with the endoplasmic reticulum membrane, catalyzes this reaction. | |||
R-HSA-193070 (Reactome) | 17-alpha-hydroxypregnenolone, NADPH + H+, and O2 react to form DHA (dehydroepiandrostenedione), NADP+, H2O, and acetaldehyde. CYP17 (which also catalyzes 17-alpha-hydroxylation) catalyzes this lyase reaction. There are marked species differences in which substrate is used for this lyase activity. The human enzyme prefers 17alpha-pregnenolone (delta5 steroid) as substrate (Brock, BJ, Waterman, MR, 1999). Corticotropin (Adrenocorticotropic hormone, ACTH) acts through the ACTH receptor called melanocortin receptor type 2 (MC2R) to stimulate steroidogenesis, increasing the production of androgens (McKenna et al, 1997). | |||
R-HSA-193072 (Reactome) | Progesterone (P4), NADPH + H+, and O2 react to form 17alpha-hydroxyprogesterone (17aHPROG), NADP+, and H2O. This reaction is catalyzed by steroid 17 alpha hydroxylase/17,20 lyase (CYP17A1), associated with the endoplasmic reticulum membrane. | |||
R-HSA-193073 (Reactome) | In this two-step reaction catalyzed by 3beta-HSD associated with the endoplasmic reticulum membrane, the 3-hydroxyl group of DHA is oxidized to a keto group and the double bond in the steroid nucleus is then isomerized from the five to the 4 position. Corticotropin (Adrenocorticotropic hormone, ACTH) acts through the ACTH receptor called melanocortin receptor type 2 (MC2R) to stimulate steroidogenesis, increasing the production of androgens (McKenna et al, 1997). | |||
R-HSA-193097 (Reactome) | Pregenolone is translocated from the mitochondrial matrix to the cytosol. Neither transport proteins to mediate its movement across the inner mitochondrial membrane nor carrier proteins to facilitate its movement in the cytosol have been identified, and the mechanism of this translocation is unknown. | |||
R-HSA-193099 (Reactome) | 17Alpha-hydroxyprogesterone (17aHPROG), NADPH + H+, and O2 react to form 4-Androstene-3, 17-dione (ANDST), NADP+, H2O, and acetaldehyde. Steroid 17 alpha hydroxylase/17,20 lyase (CYP17A1), which also catalyzes 17-alpha-hydroxylation, catalyzes this lyase reaction. | |||
R-HSA-193101 (Reactome) | 20alpha,22beta-hydroxycholesterol (20a,22b-DHCHOL), NADPH + H+, and O2 react to form pregnenolone (PREG), isocaproaldehyde (ISCAL), NADP+ and H2O. This cleavage reaction is catalysed by CYP11A (P450scc) associated with the inner mitochondrial membrane (Strushkevich et al. 2011). PREG is substantially more hydrophilic than cholesterol (CHOL) and hydroxycholesterol (HCHOL) and is released into the mitochondrial matrix. | |||
R-HSA-193143 (Reactome) | The conversion of testosterone to estradiol is catalyzed by aromatase (CYP19A1) associated with the endoplasmic reticulum membrane. | |||
R-HSA-193961 (Reactome) | Pregn-5-ene-3,20-dione-17-ol isomerizes to 17-hydroxyprogesterone. This reaction is catalyzed by the isomerase activity of 3 beta-HSD, associated with the endoplasmic reticulum membrane. The active form of the enzyme is a homodimer. The enzyme occurs in two isoforms that are similar in their biochemical properties but differ in their tissue expression: type I (HSD3B1) is found in placenta and skin, while type II (HSD3B2) is found in the adrenal glands and gonads. | |||
R-HSA-193964 (Reactome) | Progesterone, NAPDH + H+, and O2 react to form 11-deoxycorticosterone, NADP+ and H2O. This reaction is catalyzed by CYP21A2 associated with the endoplasmic reticulum membrane. | |||
R-HSA-193965 (Reactome) | 18-Hydroxycorticosterone and NADPH + H+ react to form aldosterone, NADP+, and H2O. This reaction is catalyzed by CYP11B2 associated with the inner mitochondrial membrane. | |||
R-HSA-193981 (Reactome) | 17-Hydroxyprogesterone, NADPH + H+, and O2 react to form 11-deoxycortisol, NADP+, and H2O. This reaction is catalyzed by CYP21A2 (steroid 21-hydroxylase) associated with the endoplasmic reticulum membrane. | |||
R-HSA-193995 (Reactome) | Corticosterone, NADPH + H+, and O2 react to form 18-hydroxycorticosterone, NADP+, and H2O. This reaction is catalyzed by CYP11B2 associated with the inner mitochondrial membrane. | |||
R-HSA-193996 (Reactome) | 11-deoxycorticosterone is synthesized in a reaction at the endoplasmic reticulum membrane and is further metabolized, ultimately to yield aldosterone, in reactions catalyzed by mitochondrial enzymes. The means by which 11-deoxycorticosterone translocates into the mitochondrial matrix, however, is unknown. | |||
R-HSA-193997 (Reactome) | Cytochrome P450 11B1, mitochondrial (CYP11B1) usually hydroxylates 11-deoxycortisol (11DCORT) to form cortisol (CORT). CYP11B1 is associated with the inner mitochondrial membrane. Corticotropin (Adrenocorticotropic hormone, ACTH) acts through the ACTH receptor, melanocortin receptor type 2 (MC2R) to stimulate steroidogenesis, increasing the production of androgens (McKenna et al, 1997). | |||
R-HSA-194017 (Reactome) | Cytochrome P450 11B2, mitochondrial (CYP11B2 aka aldosterone hydroxylase) is an enzyme necessary for aldosterone biosynthesis via corticosterone (CORST) and 18-hydroxycorticosterone (18HCORST). The 11-beta oxidation of 11-deoxycorticosterone (11DCORST) leads to corticosterone (CORST) and 18-hydroxylation of this leads to 18-hydroxycorticosterone (18HCORST). 18-oxidation of 18HCORST yields aldosterone. | |||
R-HSA-194023 (Reactome) | Cortisol and NADP+ react to form cortisone, NADPH, and H+. This reaction is catalyzed by 11beta-hydroxysteroid dehydrogenases 11B1 and B2 (HSD11B1, B2), associated with the endoplasmic reticulum membrane. The conversion of cortisol (CORT), an active hormone, into inactive cortisone (COR) occurs in many tissues in the body, notably in the liver, and appears to play a role in regulating cortison activity (Tannin et al. 1991, Stewart et al. 1987). | |||
R-HSA-194025 (Reactome) | 11-deoxycortisol is synthesized in a reaction at the endoplasmic reticulum membrane and is further metabolized to cortisol in a reaction catalyzed by mitochondrial enzymes. The means by which 11-deoxycortisol translocates into the mitochondrial matrix, however, is unknown. | |||
R-HSA-194036 (Reactome) | Cortisol is translocated from the mitochondrial matrix into the cytosol by an unknown mechanism. | |||
R-HSA-196060 (Reactome) | Isocaproaldehyde is reduced by NADPH + H+ to yield 4-methylpentan-1-ol and NADP+. This cytosolic reaction is catalyzed by AKR1B1 (aldose reductase). The purified human enzyme has been shown to catalyze this reaction efficiently in vitro; its abundance in adrenal tissue in humans and other mammals and its concordant expression with other enzymes of steroid hormone synthesis are consistent with it performing this role in vivo as well (Matsuura et al. 1996; Lefrancois-Martinez et al. 2004). The metabolic fate of 4-methylpentan-1-ol is unknown. | |||
R-HSA-196086 (Reactome) | Cholesterol is released from its complex with STAR in the mitochondrial intermembrane space. The mechanism of this process in vivo remains incompletely understood. | |||
R-HSA-196125 (Reactome) | Isocaproaldehyde (4-methylpentanal) is translocated from the mitochondrial matrix to the cytosol. The transporter that mediates this reaction is unknown. The reaction is inferred to exist because isocaproaldehyde is generated within the mitochondrion while the enzyme that reduces it to the corresponding alcohol is located in the cytosol (Matsuura et al. 1996). | |||
R-HSA-196126 (Reactome) | Cholesterol traverses the cytosol and the mitochondrial intermembrane space complexed with carrier proteins. This process is essential for the synthesis of steroid hormones in humans. Nevertheless, molecular details of the transport process remain incompletely understood. A plausible model, supported by studies in vitro and in cells overexpressing cloned human proteins, is that cytosolic STAR-related proteins STARD4, 5, and 6 bind cholesterol liberated from lysosomes or cytosolic lipid droplets and carry it to the outer mitochondrial membrane (Rodriguez-Aguado et al. 2005; Soccio et al. 2002), where it is transferred to STAR protein and carried across the mitochondrial intermembrane space (Miller 2007). Mutations in the gene encoding STAR block synthesis of all steroid hormones in humans, indicating the critical importance of this transport step in the biosynthetic process (Bose et al. 1996). The transport step is also a key site for normal regulation of steroid hormone synthesis, as STAR protein is unstable and its synthesis is up-regulated in response to signals such as the binding of ACTH to its receptors on adrenal cells (Stocco 2001). | |||
R-HSA-196350 (Reactome) | Pregnenolone and NAD+ react to form pregn-5-ene-3,20-dione and NADH + H+. This reaction is catalyzed by the 3 beta-hydroxysteroid activity of 3-beta-hydroxysteroid dehydrogenase/isomerase (HSD3B) enzyme associated with the endoplasmic reticulum membrane. The active form of the enzyme is a homodimer. The enzyme occurs in two isoforms that are similar in their biochemical properties but differ in their tissue expression: type I (HSD3B1) is found in placenta and skin, while type II (HSD3B2) is found in the adrenal glands and gonads. | |||
R-HSA-196372 (Reactome) | 17-Hydroxypregnenolone and NAD+ react to form pregn-5-ene-3,20-dione-17-ol and NADH + H+. This reaction is catalyzed by the 3 beta-hydroxysteroid activity of 3-beta-hydroxysteroid dehydrogenase/isomerase (HSD3B) enzyme associated with the endoplasmic reticulum membrane. The active form of the enzyme is a homodimer. The enzyme occurs in two isoforms that are similar in their biochemical properties but differ in their tissue expression: type I (HSD3B1) is found in placenta and skin, while type II (HSD3B2) is found in the adrenal glands and gonads. | |||
R-HSA-209738 (Reactome) | Vitamin D metabolites are lipophilic and must be transported in the circulation bound to plasma proteins. Vitamin D3 is transported to the liver bound to a plasma protein called vitamin D binding protein (DBP). | |||
R-HSA-209754 (Reactome) | The skin's exposure to UV rays from sunlight induces the photolytic cleavage of 7-dehydrocholesterol to previtamin D3. This is followed by thermal isomerization to form vitamin D3 (Cholecalciferol). | |||
R-HSA-209760 (Reactome) | The internalized complex enters the lysosome where it can be acted upon the protease legumain. | |||
R-HSA-209765 (Reactome) | Calcitriol (1,25(OH)2-D3) is biologically inactivated through a series of reactions beginning with 24-hydroxylation and is most likely a mechanism of elimination. 24-Hydroxylation of the vitamin D metabolites is largely regulated inversely to 1-hydroxylation, the initial step towards activation. | |||
R-HSA-209766 (Reactome) | Once out of the lysosome, calcidiol binds to intracellular vitamin D binding protein (IDBP) which facilitates the localization of vitamin D metabolites in the cell. IDBPs are related to the hsc-70 family of heat shock proteins and demonstrate a high nucleotide homology to that family. No IDBP protein has been documented yet so IDBP has not been annotated. | |||
R-HSA-209845 (Reactome) | To be functionally active, vitamin D is required to be dihydroxylated. The first hydroxylation at position 25 is carried out by vitamin D 25-hydroxylase (CYP2R1) in the liver, forming calcidiol (CDL) (Shinkyo et al. 2004). | |||
R-HSA-209868 (Reactome) | The second step in vitamin D3 activation requires hydroxylation of 25-hydroxyvitamin D3 (calcidiol, CDL) to 1alpha-25-dihydroxyvitamin D3 (calcitriol, CTL). This conversion is mediated by 25-hydroxyvitamin D-1alpha hydroxylase (CYP27B1) (Zehnder et al. 2002, Fritsche et al. 2003). | |||
R-HSA-209944 (Reactome) | Vitamin D binding protein (DBP), a plasma protein, carries the vitamin D metabolites in the circulation. Calcidiol translocates to the extracellular region where it binds with DBP and is transported to the kidney. | |||
R-HSA-350147 (Reactome) | Once vitamin D3 is released from DBP, it becomes available for hydroxylation. | |||
R-HSA-350158 (Reactome) | Mammalian legumain (asparagine-specific endoprotease) is a subfamily of cysteine proteases with no homology to other known proteases and is found in a wide range of organisms from parasites to plants and animals. Legumain requires acidic conditions for its degradative activity and has strict specificity for cleavage with an asparagine residue in the P1 site. Cubilin, once released from the complex, cycles back to the cell surface. Calcidiol also becomes available for further processing. | |||
R-HSA-350168 (Reactome) | Megalin (glycoprotein 330) is a member of the low density lipoprotein receptor family and is abundant in kidney proximal tubules. Megalin mediates the endocytic uptake of DBP:Calcidiol complexes to prevent loss of calcidiol in urine. | |||
R-HSA-350186 (Reactome) | Cubilin (CUBN) is a membrane-associated protein colocalizing with megalin. Its function is to sequester steroid carrier complexes such as vitamin D binding protein:calcidiol (GC:CDL) on the cell surface before megalin mediates their internalization (Nykjaer et al. 2001). | |||
R-HSA-469659 (Reactome) | The conversion of testosterone to the most potent androgen, 5-alpha-dihydrotestosterone (DHT), is catalyzed by the microsomal 5alpha-steroid reductase enzymes, of which there are three reported types in humans to date (SRD5A1-3) (Andersson S and Russell DW, 1990; Andersson S et al, 1991; Uemura M et al, 2008 respectively). These enzymes are expressed in the prostate and other androgen target sites. Defects in SRD5A2 are the cause of pseudovaginal perineoscrotal hypospadias, also known as male pseudohermaphroditism (Anwar R et al, 1997). Corticotropin (Adrenocorticotropic hormone, ACTH) acts through the ACTH receptor called melanocortin receptor type 2 (MC2R) to stimulate steroidogenesis, increasing the production of androgens (McKenna et al, 1997). | |||
R-HSA-804969 (Reactome) | Expression of HSD17B1 which is the main enzyme that catalyzes the hydrogenation of estrone is strongly restricted to placenta, ovaries, endometrium and breast tissue (Moeller and Adamski, 2009). | |||
SRD5A1-3 | mim-catalysis | R-HSA-469659 (Reactome) | ||
STAR | Arrow | R-HSA-196086 (Reactome) | ||
STAR | R-HSA-196126 (Reactome) | |||
StAR-related
cholesterol-binding proteins | Arrow | R-HSA-196126 (Reactome) | ||
TEST | Arrow | R-HSA-193064 (Reactome) | ||
TEST | R-HSA-193143 (Reactome) | |||
TEST | R-HSA-469659 (Reactome) | |||
VD3 | Arrow | R-HSA-209754 (Reactome) | ||
VD3 | Arrow | R-HSA-350147 (Reactome) | ||
VD3 | R-HSA-209738 (Reactome) | |||
VD3 | R-HSA-209845 (Reactome) | |||
cholesterol:STAR | Arrow | R-HSA-196126 (Reactome) | ||
cholesterol:STAR | R-HSA-196086 (Reactome) | |||
cholesterol:StAR-related protein | R-HSA-196126 (Reactome) | |||
cholesterol | Arrow | R-HSA-196086 (Reactome) | ||
cholesterol | R-HSA-193054 (Reactome) | |||
pregn-5-ene-3,20-dione-17-ol | Arrow | R-HSA-196372 (Reactome) | ||
pregn-5-ene-3,20-dione-17-ol | R-HSA-193961 (Reactome) | |||
pregn-5-ene-3,20-dione | Arrow | R-HSA-196350 (Reactome) | ||
pregn-5-ene-3,20-dione | R-HSA-193052 (Reactome) |